Vaccine News and Research

Latest Vaccine News and Research

Study explores SARS-CoV-2 spike epitope with potent and broad neutralization

Study explores SARS-CoV-2 spike epitope with potent and broad neutralization

18 Mar 2022
Study shows BCG vaccination reduces SARS-CoV-2-induced lung inflammation in hamsters

Study shows BCG vaccination reduces SARS-CoV-2-induced lung inflammation in hamsters

18 Mar 2022
Researchers argue that Omicron's lower severity is a coincidence

Researchers argue that Omicron's lower severity is a coincidence

18 Mar 2022
Breakthrough infection could provide broad protection against current SARS-CoV-2 variants of concern

Breakthrough infection could provide broad protection against current SARS-CoV-2 variants of concern

17 Mar 2022
Why does the SARS-CoV-2 Omicron variant escape immunity?

Why does the SARS-CoV-2 Omicron variant escape immunity?

17 Mar 2022
Study finds high rates of cancer among men living with HIV

Study finds high rates of cancer among men living with HIV

17 Mar 2022
Impact of new COVID vaccinations as novel variants emerge

Impact of new COVID vaccinations as novel variants emerge

17 Mar 2022
Single dose of Pfizer vaccine reduces risk of SARS-CoV-2 infection in kids

Single dose of Pfizer vaccine reduces risk of SARS-CoV-2 infection in kids

17 Mar 2022
BNT162b2 booster vaccination induces robust humoral and cellular immune responses

BNT162b2 booster vaccination induces robust humoral and cellular immune responses

17 Mar 2022
KHN’s ‘What the Health?’: We may be done with covid, but covid’s not done with us

KHN’s ‘What the Health?’: We may be done with covid, but covid’s not done with us

17 Mar 2022
It was already hard to find Evusheld, a covid prevention therapy. Now it’s even harder.

It was already hard to find Evusheld, a covid prevention therapy. Now it’s even harder.

17 Mar 2022
Evaluating vesicular stomatitis virus-based COVID-19 vaccines against SARS-CoV-2 variants in hamsters

Evaluating vesicular stomatitis virus-based COVID-19 vaccines against SARS-CoV-2 variants in hamsters

17 Mar 2022
Clinical utility of Roche assays determined utilizing samples from participants enrolled in a phase 2 trial of the mRNA-1273 vaccine

Clinical utility of Roche assays determined utilizing samples from participants enrolled in a phase 2 trial of the mRNA-1273 vaccine

17 Mar 2022
MHRA authorizes new medicine for COVID-19 prevention

MHRA authorizes new medicine for COVID-19 prevention

17 Mar 2022
Study finds serum antibody levels after BNT162b2 booster dropped significantly but remained higher than after the second dose

Study finds serum antibody levels after BNT162b2 booster dropped significantly but remained higher than after the second dose

17 Mar 2022
The immunogenicity of homologous and heterologous boosters in adults who received inactivated COVID-19 vaccine six months prior

The immunogenicity of homologous and heterologous boosters in adults who received inactivated COVID-19 vaccine six months prior

17 Mar 2022
Covid vaccination not linked to increased risk of rare neurological events

Covid vaccination not linked to increased risk of rare neurological events

17 Mar 2022
The safety and immunogenicity of NVSI-06-08 as a heterologous booster dose in adults previously vaccinated with BBIBP-CorV

The safety and immunogenicity of NVSI-06-08 as a heterologous booster dose in adults previously vaccinated with BBIBP-CorV

17 Mar 2022
Frail and older males more vulnerable to COVID-19 than females

Frail and older males more vulnerable to COVID-19 than females

17 Mar 2022
Vaccine effectiveness against COVID-19 severity in the elderly

Vaccine effectiveness against COVID-19 severity in the elderly

17 Mar 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback